About this FactMed analysis covering adverse side effect reports of ALIZAPRIDE patients who developed NAUSEA.

FactMed provides MD-approved analysis to help both patients, researchers, and physicians accurately assess the risk profile for more than 20,000 different pharmaceutical products. The below report offers compiled information from Food & Drug Administration and FactMed user submissions. Between January 2004 and October 2012, 7 individuals taking ALIZAPRIDE reported NAUSEA to the FDA. A total of 102 ALIZAPRIDE drug adverse event reaction reports were made with the FDA during this time period. Often the FDA only receives reports of the most critical and severe cases; these numbers may therefore underrepresent the complication rate of the medication.

FDA Research Report

Introduction This page is designed to help you determine the relationship, if any, between ALIZAPRIDE and NAUSEA. In doing so, we compare ALIZAPRIDE with other drugs that cause NAUSEA, to help you evaluate whether or not ALIZAPRIDE causes NAUSEA. Likewise, this page shows the most highly-reported side effects of ALIZAPRIDE, so you can see if NAUSEA ranks among ALIZAPRIDE's most well-known side effects.
Summary Statistics
Reports of ALIZAPRIDE causing NAUSEA: 7
Reports of any side effect of ALIZAPRIDE : 102
Percentage of ALIZAPRIDE patients where NAUSEA is a reported side effect: 6.8627%

FDA reports of any drug causing NAUSEA : 196083
Average percentage for all medicated patients where NAUSEA is reported as a complication: 1.2289%

Physician opinion on ALIZAPRIDE as adverse event culprit:

Overall opinion for all reports of this drug:
Most frequent diagnoses/indications for prescribing ALIZAPRIDE:
DRUG USE FOR UNKNOWN INDICATION ( 14 patients )
NAUSEA ( 14 patients )
PRODUCT USED FOR UNKNOWN INDICATION ( 3 patients )
PREMEDICATION ( 2 patients )
VOMITING ( 2 patients )
ANTIEMETIC SUPPORTIVE CARE ( 2 patients )
PROPHYLAXIS ( 1 patients )
PROPHYLAXIS OF NAUSEA AND VOMITING ( 1 patients )
( 0 patients )
Drugs with high FDA adverse event association with NAUSEA:

BYETTA (15071 patients)
CHANTIX (13928 patients)
ASPIRIN (12650 patients)
FOSAMAX (7433 patients)
HEPARIN SODIUM INJECTION (7233 patients)
NEXIUM (6749 patients)
METFORMIN HCL (6333 patients)
LIPITOR (6255 patients)
VIOXX (6108 patients)
SYNTHROID (5985 patients)
HUMIRA (5972 patients)
FORTEO (5969 patients)
LISINOPRIL (5903 patients)
PREDNISONE (5277 patients)
LASIX (5032 patients)
CYMBALTA (4911 patients)
XANAX (4610 patients)
SEROQUEL (4533 patients)
ENBREL (4346 patients)
OMEPRAZOLE (4309 patients)
REMICADE (4304 patients)
METHOTREXATE (4200 patients)
PRILOSEC (4108 patients)
PAXIL (4094 patients)
ATENOLOL (4086 patients)
YAZ (4038 patients)
LYRICA (3997 patients)
NEURONTIN (3936 patients)
SIMVASTATIN (3934 patients)
FOLIC ACID (3894 patients)
LANTUS (3887 patients)
HYDROCHLOROTHIAZIDE (3850 patients)
ZOLOFT (3771 patients)
COUMADIN (3684 patients)
ACETAMINOPHEN (3657 patients)
DIGOXIN (3630 patients)
YASMIN (3608 patients)
OXYCONTIN (3574 patients)
AMBIEN (3561 patients)
PROTONIX (3554 patients)
PLAVIX (3541 patients)
FUROSEMIDE (3479 patients)
IBUPROFEN (3449 patients)
LEXAPRO (3310 patients)
ZOMETA (3300 patients)
LEVOTHYROXINE SODIUM (3280 patients)
ZOFRAN (3244 patients)
NORVASC (3238 patients)
ALBUTEROL (3237 patients)
PREVACID (3210 patients)
TOPROL-XL (3177 patients)
TYSABRI (3092 patients)
VITAMIN D (3056 patients)
GLUCOPHAGE (3041 patients)
ZOCOR (3037 patients)
SANDOSTATIN LAR (2915 patients)
ATIVAN (2914 patients)
POTASSIUM CHLORIDE (2880 patients)
VICTOZA (2876 patients)
VICODIN (2872 patients)
LORAZEPAM (2869 patients)
CELEBREX (2852 patients)
CRESTOR (2747 patients)
DURAGESIC-100 (2656 patients)
RIBAVIRIN (2654 patients)
CALCIUM (2650 patients)
CISPLATIN (2633 patients)
PERCOCET (2588 patients)
ACTOS (2504 patients)
DEXAMETHASONE (2417 patients)
GABAPENTIN (2391 patients)
LEVAQUIN (2368 patients)
AVONEX (2337 patients)
ALLOPURINOL (2257 patients)
ADVAIR DISKUS 100/50 (2252 patients)
EFFEXOR (2250 patients)
PROZAC (2249 patients)
PEGASYS (2247 patients)
OXYCODONE HCL (2242 patients)
DIOVAN (2238 patients)
GLEEVEC (2213 patients)
CLONAZEPAM (2158 patients)
PREMARIN (2149 patients)
FLUOROURACIL (2130 patients)
MORPHINE (2110 patients)
CARBOPLATIN (2108 patients)
KLONOPIN (2086 patients)
METFORMIN (2079 patients)
AVANDIA (2072 patients)
GLIPIZIDE (2064 patients)
PREDNISOLONE (2058 patients)
WELLBUTRIN (2051 patients)
METOPROLOL TARTRATE (2045 patients)
PREDNISONE TAB (2038 patients)
AMARYL (2034 patients)
EXJADE (1991 patients)
MULTI-VITAMINS (1990 patients)
ACCUTANE (1983 patients)
AREDIA (1971 patients)
DECADRON (1969 patients)
INSULIN (1953 patients)
ALPRAZOLAM (1952 patients)
WARFARIN SODIUM (1940 patients)
AMLODIPINE (1928 patients)
SINGULAIR (1918 patients)
MULTI-VITAMIN (1902 patients)
EFFEXOR XR (1876 patients)
COREG (1852 patients)
PRISTIQ (1833 patients)
TRAMADOL HCL (1832 patients)
BENADRYL (1825 patients)
COMPAZINE (1821 patients)
HEPARIN SODIUM (1790 patients)
LORTAB (1786 patients)
GLYBURIDE (1785 patients)
ZANTAC (1785 patients)
FENTANYL (1778 patients)
NIASPAN (1772 patients)
ZYRTEC (1726 patients)
XELODA (1725 patients)
MIRENA (1714 patients)
SPIRIVA (1694 patients)
CELEXA (1672 patients)
VALIUM (1667 patients)
REGLAN (1634 patients)
NEXAVAR (1616 patients)
TRAZODONE HCL (1605 patients)
LAMICTAL (1585 patients)
NITROGLYCERIN (1584 patients)
HUMALOG (1577 patients)
CYCLOPHOSPHAMIDE (1576 patients)
DIAZEPAM (1555 patients)
SPIRONOLACTONE (1540 patients)
SOLIRIS (1534 patients)
METOPROLOL (1514 patients)
PROMETHAZINE (1514 patients)
FISH OIL (1493 patients)
VITAMIN B-12 (1492 patients)
TYLENOL (CAPLET) (1479 patients)
TYLENOL (1478 patients)
ZETIA (1461 patients)
AVASTIN (1440 patients)
DILAUDID (1439 patients)
METOCLOPRAMIDE (1431 patients)
ALLEGRA (1420 patients)
ASCORBIC ACID (1408 patients)
PEG-INTRON (1404 patients)
TOPAMAX (1404 patients)
REVLIMID (1395 patients)
COZAAR (1385 patients)
ORTHO EVRA (1381 patients)
RANITIDINE (1366 patients)
AVELOX (1355 patients)
BONIVA (1333 patients)
VALTREX (1315 patients)
ONDANSETRON (1309 patients)
PLAN B ONE-STEP (1300 patients)
LANSOPRAZOLE (1285 patients)
AMOXICILLIN (1282 patients)
FLEXERIL (1280 patients)
CALCIUM CARBONATE (1278 patients)
CAPECITABINE (1275 patients)
COLACE (1269 patients)
REBIF (1259 patients)
OXALIPLATIN (1254 patients)
VITAMIN E (1247 patients)
LEVOXYL (1239 patients)
ACTONEL (1237 patients)
MORPHINE SULFATE (1231 patients)
CLONIDINE (1228 patients)
SUTENT (1223 patients)
PANTOPRAZOLE (1220 patients)
ALTACE (1212 patients)
NAPROXEN (1205 patients)
TAXOL (1197 patients)
NOVOLOG (1197 patients)
CIPROFLOXACIN (1181 patients)
HYDROCODONE (1173 patients)
LOPRESSOR (1160 patients)
STRATTERA (1154 patients)
CITALOPRAM HYDROBROMIDE (1150 patients)
PHENERGAN (1146 patients)
FLUCONAZOLE (1144 patients)
BACTRIM (1135 patients)
ACIPHEX (1129 patients)
BACLOFEN (1119 patients)
PEPCID (1117 patients)
AMITRIPTYLINE HCL (1108 patients)
FLONASE (1107 patients)
VELCADE (1105 patients)
TAXOTERE (1103 patients)
ALL OTHER THERAPEUTIC PRODUCTS (1093 patients)
ENALAPRIL MALEATE (1085 patients)
RAMIPRIL (1083 patients)
ULTRAM (1081 patients)
ACETYLSALICYLIC ACID (1080 patients)
LOVENOX (1080 patients)
ZYPREXA (1071 patients)
ACYCLOVIR (1071 patients)
KETEK (1070 patients)
VITAMINS (1062 patients)
CLARITIN (1057 patients)
TRICOR (1046 patients)
GILENYA (1045 patients)
ZITHROMAX (1042 patients)
VYTORIN (1041 patients)
METOPROLOL SUCCINATE (1038 patients)
PAROXETINE HCL (1037 patients)
MOTRIN (1036 patients)
DIANEAL (1021 patients)
Most common side effects for patients taking ALIZAPRIDE:
DIARRHOEA (16 patients)
PYREXIA (16 patients)
VOMITING (10 patients)
FATIGUE (9 patients)
HYPOKALAEMIA (9 patients)
DEHYDRATION (8 patients)
NAUSEA (7 patients)
ANAEMIA (6 patients)
ASTHENIA (6 patients)
BRONCHOPNEUMONIA (6 patients)
DRUG INTERACTION (6 patients)
DYSPNOEA (6 patients)
HYPOTENSION (6 patients)
PNEUMONIA (6 patients)
GENERAL PHYSICAL HEALTH DETERIORATION (5 patients)
HAEMORRHAGE (5 patients)
HYPOMAGNESAEMIA (5 patients)
HYPOPHOSPHATAEMIA (5 patients)
JAUNDICE (5 patients)
RESPIRATORY FAILURE (5 patients)
SOMNOLENCE (5 patients)
TACHYCARDIA (5 patients)
ABDOMINAL PAIN (4 patients)
ADVERSE DRUG REACTION (4 patients)
FALL (4 patients)
HAEMODIALYSIS (4 patients)
HAEMOGLOBIN DECREASED (4 patients)
INTESTINAL OBSTRUCTION (4 patients)
MALAISE (4 patients)
SLEEP APNOEA SYNDROME (4 patients)
SUPRAVENTRICULAR TACHYCARDIA (4 patients)
THROMBOCYTHAEMIA (4 patients)
THROMBOCYTOPENIA (4 patients)
WHITE BLOOD CELL COUNT DECREASED (4 patients)
ACUTE RESPIRATORY DISTRESS SYNDROME (3 patients)
BACTERIAL SEPSIS (3 patients)
BLOOD BILIRUBIN INCREASED (3 patients)
BLOOD CREATININE INCREASED (3 patients)
DECREASED APPETITE (3 patients)
DERMATITIS EXFOLIATIVE (3 patients)
DEVICE DISLOCATION (3 patients)
ENTERITIS (3 patients)
FEBRILE NEUTROPENIA (3 patients)
FIBRIN D DIMER INCREASED (3 patients)
FUSOBACTERIUM INFECTION (3 patients)
HAEMOPTYSIS (3 patients)
HYPOXIA (3 patients)
ILEUS (3 patients)
LEUKAEMIA RECURRENT (3 patients)
MUCOSAL INFLAMMATION (3 patients)
NEUROTOXICITY (3 patients)
NEUTROPENIA (3 patients)
OVERDOSE (3 patients)
PRESYNCOPE (3 patients)
PROTEUS INFECTION (3 patients)
RASH (3 patients)
RENAL FAILURE ACUTE (3 patients)
SEPTIC SHOCK (3 patients)
SUPERINFECTION (3 patients)
TONGUE DISORDER (3 patients)
ACUTE PULMONARY OEDEMA (2 patients)
AGRANULOCYTOSIS (2 patients)
ATRIAL FIBRILLATION (2 patients)
BLOOD FIBRINOGEN INCREASED (2 patients)
BLOOD GLUCOSE INCREASED (2 patients)
BONE MARROW DEPRESSION (2 patients)
BONE MARROW FAILURE (2 patients)
BRONCHOPULMONARY ASPERGILLOSIS (2 patients)
C-REACTIVE PROTEIN INCREASED (2 patients)
CHILLS (2 patients)
COLITIS ISCHAEMIC (2 patients)
CONSTIPATION (2 patients)
CONVULSION (2 patients)
CORONARY ARTERY DISEASE (2 patients)
DEAFNESS (2 patients)
DIZZINESS (2 patients)
DRUG ADMINISTRATION ERROR (2 patients)
DYSPHAGIA (2 patients)
DYSURIA (2 patients)
EJECTION FRACTION DECREASED (2 patients)
ERYSIPELAS (2 patients)
FACIAL PALSY (2 patients)
FEBRILE BONE MARROW APLASIA (2 patients)
FLATULENCE (2 patients)
GASTROENTERITIS (2 patients)
HAEMATOCRIT DECREASED (2 patients)
HYPERSENSITIVITY (2 patients)
INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION (2 patients)
INFECTION (2 patients)
KLEBSIELLA SEPSIS (2 patients)
LEUKOPENIA (2 patients)
LYMPHANGITIS (2 patients)
LYMPHOCYTE COUNT INCREASED (2 patients)
NERVOUS SYSTEM DISORDER (2 patients)
NEUTROPHIL COUNT DECREASED (2 patients)
OEDEMA MUCOSAL (2 patients)
OTITIS MEDIA (2 patients)
PANCYTOPENIA (2 patients)
PARTIAL SEIZURES (2 patients)
PLATELET COUNT DECREASED (2 patients)
PULMONARY EMBOLISM (2 patients)
RED BLOOD CELL COUNT DECREASED (2 patients)
RENAL FAILURE (2 patients)
RHINORRHOEA (2 patients)
SHOCK (2 patients)
STREPTOCOCCAL SEPSIS (2 patients)
SUDDEN CARDIAC DEATH (2 patients)
URTICARIA (2 patients)
ACCIDENTAL OVERDOSE (1 patients)
ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE (1 patients)
ACUTE GRAFT VERSUS HOST DISEASE IN SKIN (1 patients)
AGITATION (1 patients)
ALVEOLITIS (1 patients)
ANOREXIA (1 patients)
ANXIETY (1 patients)
APHASIA (1 patients)
APHTHOUS STOMATITIS (1 patients)
ARACHNOIDITIS (1 patients)
BLOOD CULTURE POSITIVE (1 patients)
CALCULUS URINARY (1 patients)
CANDIDA SEPSIS (1 patients)
CANDIDIASIS (1 patients)
CARDIO-RESPIRATORY ARREST (1 patients)
CENTRAL NERVOUS SYSTEM LEUKAEMIA (1 patients)
CEREBRAL HAEMORRHAGE (1 patients)
CHEST PAIN (1 patients)
COLITIS (1 patients)
CONFUSIONAL STATE (1 patients)
COUGH (1 patients)
CYANOSIS (1 patients)
DIARRHOEA INFECTIOUS (1 patients)
DISEASE PROGRESSION (1 patients)
DISLOCATION OF VERTEBRA (1 patients)
DOCUMENTED HYPERSENSITIVITY TO ADMINISTERED DRUG (1 patients)
DRUG HYPERSENSITIVITY (1 patients)
DRUG TOXICITY (1 patients)
DRY SKIN (1 patients)
ENCEPHALOPATHY (1 patients)
EPILEPSY (1 patients)
ERYTHEMA (1 patients)
FLUSHING (1 patients)
GAMMA-GLUTAMYLTRANSFERASE INCREASED (1 patients)
GENERAL PHYSICAL CONDITION ABNORMAL (1 patients)
GRAFT VERSUS HOST DISEASE (1 patients)
HAEMATURIA (1 patients)
HEADACHE (1 patients)
HYPERBILIRUBINAEMIA (1 patients)
HYPERTENSIVE CRISIS (1 patients)
HYPOACUSIS (1 patients)
HYPOAESTHESIA (1 patients)
HYPOCALCAEMIA (1 patients)
HYPOMANIA (1 patients)
HYPOVOLAEMIC SHOCK (1 patients)
KLEBSIELLA INFECTION (1 patients)
LACTOSE INTOLERANCE (1 patients)
LEUKAEMIA PLASMACYTIC (1 patients)
METASTATIC NEOPLASM (1 patients)
MULTI-ORGAN FAILURE (1 patients)
MULTIPLE MYELOMA (1 patients)
MUSCULAR WEAKNESS (1 patients)
MYALGIA (1 patients)
MYOGLOBIN BLOOD INCREASED (1 patients)
NEOPLASM (1 patients)
NEURALGIA (1 patients)
OEDEMA (1 patients)
OEDEMA PERIPHERAL (1 patients)
PAIN (1 patients)
PARESIS (1 patients)
PNEUMONIA KLEBSIELLA (1 patients)
PNEUMONITIS (1 patients)
PRODUCTIVE COUGH (1 patients)
PRURITUS (1 patients)
PULMONARY ALVEOLAR HAEMORRHAGE (1 patients)
PULMONARY HYPERTENSION (1 patients)
RADIUS FRACTURE (1 patients)
RASH GENERALISED (1 patients)
RASH MACULAR (1 patients)
RASH MACULO-PAPULAR (1 patients)
RENAL COLIC (1 patients)
RESPIRATORY DISTRESS (1 patients)
RIGHT VENTRICULAR DYSFUNCTION (1 patients)
SEPSIS (1 patients)
SKIN LESION (1 patients)
SPUTUM PURULENT (1 patients)
STAPHYLOCOCCAL BACTERAEMIA (1 patients)
STEM CELL TRANSPLANT (1 patients)
STOMATITIS (1 patients)
THROMBOSIS (1 patients)
THROMBOTIC MICROANGIOPATHY (1 patients)
TOXICITY TO VARIOUS AGENTS (1 patients)
ULNA FRACTURE (1 patients)
WEIGHT DECREASED (1 patients)

In addition to reviewing our up-to-date FDA research, users may interact with the FactMed community - currently one million members and growing! FactMed online research and discussions are read by patients, scientists, physicians, and other interested health care parties. Post follow up Questions to learn from our diverse readership. Likewise, patients who have experienced unwanted effects are encouraged to share their Concerns to help educate and inform our members.


Recent FactMed Activity for ALIZAPRIDE


Issue Description / Topic Timestamp

My Patient Resources

Get your questions answered! Over one million patients, researchers, and health care providers have visited FactMed. If you have a question about NAUSEA and ALIZAPRIDE, post it here. You may receive a response from a fellow patient - or a leading expert in the field.
Your Question:

Share your experience: Over one million patients, researchers, and health care providers have visited FactMed. If you have a noteworthy experience as a patient taking ALIZAPRIDE, post it here. Your story could help a fellow patient - or provide insight to a leading expert in the field.
Your Experience or Concern:

Telemedicine Expert Consults FactMed newest feature allows patients to consult - via realtime videoconferencing - experts in ALIZAPRIDE. This premium feature connects patients to experts, regardless of geography. FactMed experts charge reasonable rates that may be reimbursable by your insurance as a second-opinion.
We are currently accepting registration for ALIZAPRIDE experts. If you are a healthcare provider experienced in prescribing ALIZAPRIDE, please register here.

Your online appointment book for Pryor Rentals & Services

© 2014 FactMed, Inc
Privacy Policy
Terms of Use